Luteinizing hormone
Jump to navigation
Jump to search
| Luteinizing hormone | |
|---|---|
| Term | Luteinizing hormone |
| Short definition | luspatercept (lus-PA-ter-cept) A drug used to treat anemia in adults with certain types of myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms who require regular red blood cell transfusions and whose anemia does not has responded to or cannot be treated with an erythropoiesis-stimulating agent. Luspatercept is also used to treat anemia in adults with beta-thalassemia (an inherited blood disorder) who need regular red blood cell transfusions. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
luteinizing hormone - (pronounced) (LOO-tih-NY-zing HOR-mone) A hormone produced in the pituitary gland. In women, it acts on the ovaries to encourage the follicles to release their eggs and to produce hormones that prepare the uterus for implantation of a fertilized egg. In men, it acts on the testicles to grow cells and produce testosterone. Also known as interstitial cell stimulating hormone, LH and lutropin
External links
- Medical encyclopedia article on Luteinizing hormone
- Wikipedia's article - Luteinizing hormone
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski